Opportunity Overview
The U.S. Food and Drug Administration has an active presolicitation for Automated Liquid Handling Platform, 75F40126Q00423, for one newly manufactured benchtop automated liquid handling system.
Deadline
The current SAM.gov response date is September 22, 2026 at 11:00 AM Eastern Daylight Time. The September 17 presolicitation supersedes the earlier September 11 response date associated with the prior notice state.
Scope
The platform must fit and operate within a specified biosafety cabinet, perform automated pipetting and serial dilutions in 96-well and 384-well formats, use interchangeable 96-channel and 384-channel heads with independent tip pickup, provide at least a 15-position deck, and dispense 0.1 to 200 microliters within the stated accuracy and precision requirements.
The requirement also calls for a controller, protocol-development software, a dedicated computer, compatibility with standard microplates, and the ability to support future shaking, heating, cooling, and filtration configurations. FDA’s market research identifies the Agilent Technologies Bravo Automated Liquid Handling Platform as the model that meets the stated minimum needs.
Competition and Classification
The current presolicitation lists no set-aside. NAICS is 334516, Analytical Laboratory Instrument Manufacturing, and PSC is 6640, Laboratory Equipment and Supplies.
Funding / Contract Value
No fixed maximum contract value is stated in the public notice.
Qualification Guidance
Potential respondents should review the live presolicitation for the current acquisition approach and confirm compliance with the new-equipment requirement, biosafety-cabinet dimensions and load, pipetting range and performance, deck configuration, software and controller requirements, future modular capabilities, safety requirements, and all response instructions.